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100% specific for the 59 strains tested. For part 2: Out of the 40 specimens,
6 MDRA were detected: 4 by all the agars, 1 picked up by Hardy alone (non-
MDRA acinetobacter by the others), 1 picked by both CHROMagar and Hardy
(non-MDRA acinetobacter by m-LAM). Upon re-examination, multiple col-
onies with different susceptibility profile were found on the agars. Discrep-
ancy was likely due to chance of picking the resistant colonies. For the 34
non-MDRA specimens, follow up tests were required in 6 when using m-
LAM, 13 when using Hardy, and 5 when using CHROMagar.
Figure. Appearances of MDRA in the three tested MDRA selective agars.
Conclusions: The three tested selective agar media have good sensitivity
and specificity for detecting MDRA. Each has its own advantage and disad-
vantage and the choice should be made by individual laboratories.PS 2-327
EPIDEMIOLOGY OF CANDIDEMIA IN A MEDICAL CENTER IN MIDDLE
TAIWAN
Hui-Lan Chang a, Li-Jhen Lin a, Ing-Moi Hii b, Chun-Eng Liu a,b. aInfection
Control Committee, Changhua Christian Hospital, Changhua, Taiwan;
bDepartment of Internal Medicine, Changhua Christian Hospital, Changhua,
Taiwan
Purpose: Opportunistic pathogens such as yeast infections caused by
Candida bacteremia (Candidemia),Clinical morbidity and mortality is still
an important reason.This experiment was collected from 2009 to 2012 in
Taiwan Medical Center clinical laboratory data were retrospective study of
patients with candidemia.
Methods: To test the disk colorimetric microdilution,Configure the appro-
priate dilution test disc antibiotics and coloring indicator,After the addition
of non-critical liquid yeast culture,In manual interpretation manner lowest
antifungal concentration observed inhibition of microbial growth, fungal
drug susceptibility testing operation,Understanding of the distribution and
drug susceptibility against fungal change clinical pathogenic yeast.
Results
Candida albicans accounted for 45.2%, Candida tropicalis 22.3%, Candida
glabrata 21.8%, Candida parapsilosis 8.5%, Candida krusei 1.1% and 1% oth-
er.Gender distinction, men 63.3%, women 36.7%.To distinguish between age
0 to 20 years old 4.3%, 5.9% from 21 to 40 years old, 41 to 60 years 19.7%
47.9% 61 to 80 years, 22.3 percent of 81 to 100 years old.In 2009 and 2012
isolates, a total of 188 cases of patients with candidemia in this study.
Conclusions: The experiments showed that the most frequently isolated re-
mains C.albicans,Others in sequence for C.tropicalis, C.glabrata, C.parapsi-
losis and C.krusei ... etc.Amphotericin B, Posaconazole drug susceptibility
testing,CLSI M27-S3 No interpretation no breakpoint therefore to represent.
Anidulafungin, Micafungin this experiment Candida spp.Are all Suscepti-
ble.C.glabrata, C.tropicalis drugs Susceptible lower. Necessary with focus
on prompt identification of patients at risk for candidemia due to resistant
strains and the effect of appropriate antifungal therapy on mortality.
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THE MANAGERIAL EXPERIENCE OF REUSE OF SINGLE-USE MEDICAL
DEVICES
Li-Jhen Lin a, Hui-Lan Chang a, Chun-Eng Liu a,b. aInfection control
Committee, Changhua Christian Hospital, Taiwan; bInformation Technology
Department, Changhua Christian Hospital, Taiwan
Purpose: To develop audit procedure and administration policy for reuse of
single-use medical devices so that the introduction of these devices intoclinical practices can be regulated to prevent increasing risk of infection
due to inappropriate reuse of these devices on patients.
Material and methodology:
1. Resource management department receives the application from the
“team for incoming new medical materials” and reminds the applicants
of clinical units to complete the application via electronic administra-
tion system with attachment of the “audit form for resuse of single-use
medical devices” approved by the IPC center.
2. The single-use medical devices can be reused only after the application
is approved by the IPC center and co-signed by the associated
committees.
3.All units stipulate the items and management policy of reusable single-
use devices.
4. The clinical units record and report defective rate and expired rate of
reusable single-use medical devices quarterly; and count the number of
reused single-use medical devices, document the identification and
tracking of exposed patients and perform testing for reusable medical
devices monthly.
5. After comparison to the data between infection control information
system and laboratory information system, the medical technologist
of IPC center inform the physicians and clinical units about suspected
cases.
6. The IPC center irregularly check the management policy of reusable
medical devices in each unit.
7. The annular check report of reused medical devices from IPC center
will be feedback to each unit
Results: Quality management index:1. The monthly associated complication
rate of reusable medical devices2. The qualified rate of reusable medical de-
vices3. The quarterly defective rate of reusable medical devices
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EFFICIENT ENVIRONMENT SURVEILLANCE CULTURE MONITORING
ACTIVITIES WITH DEVELOPING COMPUTER PROGRAM
Soon Im Choi a, Kyung Hee Lee a, Chun Soo Kim a, Nam Hee Ryoo a,c, Sung
Yeul Ryu a,b, Jin Ho Cheon d, Dong Jin Jeong c. aInfection Control Team,
Dongsan Medical Center; bDepartment of Internal Medicine, Keimyung
University, Daegu, South Korea; cLaboratory Medicine, Keimyung University,
Daegu, South Korea; dElectronic Data Center, Dongsan Medical Center
Purpose: In the field of infection control, it is important to maintain and
disinfect a clean environment as much as hand hygiene because spreading
of bacteria is mainly through polluted surface or medical instruments.
Some department conducts test for environment surveillance cultures regu-
larly. This test should be well-organized, qualified, and revised every year. In
order to manage scattered items of all departments efficiently, infection
control team is in charge of developing ‘environment surveillance culture’
computation program.
Methods:
1. The overview of Environment Surveillance Culture computation program
(1) Registration of common items for ‘environment surveillance cultures’
(2) Request and enrollment of examinations from each department
through program, without submitting cooperation document
(3) Registration to Department of Laboratory Medicine
(4) Laboratory Medicine specialists confirm the result and attach comment.
(5) The department registered items check the result.
2. Education and promotion of use of the program
3. Evaluate the necessity of test and confirm the results.
4. The important notice is uploaded to intra-office network page.
5. Establish documented method of environmental surveillance culture.
6. Through the program, it is easy to request tests, see the results, and
simplify the procedure.
Results:
1. Infection Control Team generalizes all procedures and coordinates each
department.
2. Set the test date by using program and the lab manage possible dates for
high-efficiency.
3. By posting the result of working place safety result to intra-office network
page.
